论文部分内容阅读
由人口委员会(Population Council)发展的含孕激素一左旋18甲基炔诺酮(Levonorgestrel)的硅橡胶皮下缓释系统(Norplant)经芬兰药物管理局(the Drug Regulatory Authorities of Finland)批准临床应用。作者对124例有生育能力、月经正常的健康育龄妇女进行了为期5年的临床观察。 124例妇女平均年龄为29.1岁(20～35岁),产次0～1次占55%,2次以上者45%。在月经来潮后7天内于前臂内侧皮下埋植Norplant。埋植术在局麻下进行,术后1、3、6个月进行随访,此后每半年随访一次,若出现症状或需取出时随时进行随访。术前及随访时均进行全身检查、妇科检
The silicone rubber subcutaneous slow release system (Proplant) containing progestogen-levonorgestrel developed by the Population Council has been approved for clinical use by the Drug Regulatory Authorities of Finland. The author of 124 cases of fertility, normal menstruation women of childbearing age for a 5-year clinical observation. The average age of 124 women was 29.1 years (20-35 years), with 55% of births occurring 0-1 times and 45% of those having 2 times or more. Norplant is implanted subcutaneously in the medial forearm within 7 days of menstrual cramps. Buried under local anesthesia, 1,3,6 months after the follow-up, followed up every six months, if symptoms or need to be removed at any time follow-up. Preoperative and follow-up were carried out during the whole body examination, gynecological examination